Metoprolol Succinate Extended Release Tablets

Kraj: Nowa Zelandia

Język: angielski

Źródło: Medsafe (Medicines Safety Authority)

Składnik aktywny:

Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg

Dostępny od:

AFT Pharmaceuticals Ltd

INN (International Nazwa):

Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)

Dawkowanie:

23.75 mg

Forma farmaceutyczna:

Modified release tablet

Skład:

Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres

Typ recepty:

Prescription

Wyprodukowano przez:

Watson Pharma Private Limited

Wskazania:

Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Podsumowanie produktu:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C

Data autoryzacji:

2016-06-24